Cleveland BioLabs' Unattributed VC Round

Cleveland BioLabs raised a round of funding on March 18, 2005.

Cleveland BioLabs (NASDAQ: CBLI) is a biopharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. The company's proprietary platform of toll-…

Articles about Cleveland BioLabs' Unattributed VC Round: